Source: BioPortfolio

CaroGen: CaroGen Corp Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 26072017 Prices from USD $250

SummaryCaroGen Corp CaroGen is a vaccine company that offers platform technology development services. The company develops and commercializes nanoparticle therapeutic vaccines. It utilizes its viruslike vesicle platform technology a proprietary replicatio...

Read full article »
CaroGen's Competitors | CaroGen's News | CaroGen's Financials
Stay up-to-date with the latest news on CaroGen
Est. Annual Revenue
$100K-5.0M
Est. Employees
25-100
Bijan Almassian's photo - President & CEO of CaroGen

President & CEO

Bijan Almassian

CEO Approval Rating

83/100

Read more
Stay up-to-date with the latest news on CaroGen